atezolizumab,bevacizumab
roche
['gyn', 'improve ', 'atalante', 'ovarian', 'platinum', 'atezo']
at #esmo22: data from the atalante study showed that adding atezolizumab to platinum-based chemotherapy does not improve progression-free survival in relapsed ovarian cancer. #gyncsm #gynonc 
https://t.co/bi63MIVP5D is a resource offering oncology health care professionals practical information about the changing clinical landscape.